SCHEMBL30714540

SCHEMBL30714540

Cc1ccc(N)cc1-c1cccnc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AXL P30530 2/20 0.56
MKNK1 Q9BUB5 2/20 0.56
MKNK2 Q9HBH9 2/20 0.56
MEN1 O00255 1/20 0.56
PSIP1 O75475 1/20 0.56
CYP2A6 P11509 5/20 0.51
CYP3A4 P08684 3/20 0.51
CYP2E1 P05181 2/20 0.51
CYP2D6 P10635 2/20 0.51
CYP2C9 P11712 2/20 0.51
CYP2B6 P20813 2/20 0.51
CYP2C19 P33261 2/20 0.51
ABL1 P00519 1/20 0.51
BCR P11274 1/20 0.51
CYP11B1 P15538 3/20 0.49
CYP11B2 P19099 2/20 0.49
CYP19A1 P11511 1/20 0.49
TDO2 P48775 1/20 0.47
ALDH1A1 P00352 1/20 0.47
CYP1A2 P05177 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1439800 1.00 AXL (0.56) AXLMKNK1MKNK2MEN1PSIP1
SCHEMBL4724843 0.85 MKNK1 (0.56) AXLMKNK1MKNK2MEN1PSIP1
SCHEMBL16405695 0.84 AXL (0.61) AXLMKNK1MKNK2MEN1PSIP1
SCHEMBL14003400 0.82 CYP2A6 (0.54) MKNK1MKNK2CYP2A6CYP3A4CYP2E1
SCHEMBL145074 0.82 AXL (0.59) AXLMKNK1MKNK2MEN1PSIP1
SCHEMBL16405697 0.82 AXL (0.51) AXLMKNK1MKNK2MEN1PSIP1
SCHEMBL22206280 0.81 ABL1 (0.63) AXLMKNK1MKNK2MEN1PSIP1
SCHEMBL29394740 0.81 CYP2A6 (0.61) MKNK1MKNK2CYP2A6CYP3A4CYP2E1
SCHEMBL16405701 0.81 AXL (0.50) AXLMKNK1MKNK2MEN1PSIP1
Hydrochloric Acid SCHEMBL6739740 0.81 AXL (0.58) AXLMKNK1MKNK2MEN1PSIP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4536637-A2 COMPOUNDS, COMPOSITIONS, AND METHODS Nico Therapeutics, Inc. (US) 2025-04-16 EP disclosed
WO-2023240084-A2 COMPOUNDS, COMPOSITIONS, AND METHODS DENALI THERAPEUTICS INC. (US) 2023-12-14 WO disclosed